# The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action

> **NCT05414409** · PHASE2 · RECRUITING · sponsor: **Heba M. Ismail** · enrollment: 114 (estimated)

## Conditions studied

- Type 1 Diabetes
- Obesity

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05414409
- **Lead sponsor:** Heba M. Ismail
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-30
- **Primary completion:** 2026-11-02
- **Final completion:** 2026-11-02
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2025-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414409, "The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05414409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*